| Literature DB >> 19121307 |
Hauke Schmidt1, Jenni Raasch, Doron Merkler, Florian Klinker, Sandra Krauss, Wolfgang Brück, Marco Prinz.
Abstract
The type I interferons, interferon-beta and alpha (IFN-beta, IFN-alpha), are widely used for the treatment of autoimmune demyelination in the central nervous system (CNS). Their effects on de- and remyelination through the broadly expressed type I IFN receptor (IFNAR), however, are highly speculative. In order to elucidate the role of endogenous type I interferons for myelin damage and recovery we induced toxic demyelination in the absence of IFNAR1. We demonstrate that IFNAR signalling was induced during acute demyelination since the cytokine IFN-beta as well as the IFN-dependent genes IRF7, ISG15 and UBP43 were strongly upregulated. Myelin damage, astrocytic and microglia response, however, were not significantly reduced in the absence of IFNAR1. Furthermore, motor skills of IFNAR1-deficient animals during non-immune demyelination were unaltered. Finally, myelin recovery was found to be independent from endogenous IFNAR signalling, indicating a redundant role of this receptor for non-inflammatory myelin damage and repair.Entities:
Mesh:
Substances:
Year: 2008 PMID: 19121307 DOI: 10.1016/j.expneurol.2008.12.002
Source DB: PubMed Journal: Exp Neurol ISSN: 0014-4886 Impact factor: 5.330